Related Experiment Videos

Ascorbic acid status in idiopathic hemochromatosis

Digestion
|January 1, 1978
PubMed

Insights

Idiopathic hemochromatosis patients show vitamin C deficiency, particularly when untreated. Treatment for this iron overload condition effectively restores vitamin C levels.

Area of Science:

  • Biochemistry
  • Hematology
  • Nutritional Science

Background:

  • Idiopathic hemochromatosis is a genetic disorder characterized by excessive iron absorption and storage.
  • Vitamin C (ascorbic acid) plays a crucial role in iron metabolism and antioxidant defense.
  • Altered vitamin C status has been anecdotally reported in various chronic diseases.

Purpose of the Study:

  • To investigate vitamin C status in patients with idiopathic hemochromatosis.
  • To compare vitamin C levels between untreated and treated idiopathic hemochromatosis patients and control groups.
  • To explore the relationship between iron overload and vitamin C deficiency in this condition.

Main Methods:

  • Leukocyte ascorbic acid concentrations were measured as an indicator of vitamin C status.
  • Study included 67 idiopathic hemochromatosis patients (44 untreated, 25 treated), 31 normal subjects, and 37 alcoholic cirrhosis patients.
  • Statistical analysis compared mean vitamin C levels across different groups.

Main Results:

  • Untreated idiopathic hemochromatosis patients exhibited significantly lower vitamin C levels (19.5 +/- 1.7 microgram/10(8) WBC) compared to normal controls (34.4 +/- 1.9 microgram/10(8) WBC).
  • Treated idiopathic hemochromatosis patients showed restored vitamin C levels (34.3 +/- 2.3 microgram/10(8) WBC), comparable to normal subjects.
  • Alcoholic cirrhosis patients had reduced vitamin C levels (22.0 +/- 1.8 microgram/10(8) WBC).

Conclusions:

  • A significant vitamin C deficiency is present in untreated idiopathic hemochromatosis.
  • Iron overload appears to be the primary cause of vitamin C deficiency in idiopathic hemochromatosis.
  • This deficiency can lead to underestimation of desferrioxamine-induced urinary iron excretion in these patients.

Related Concept Videos